ASPHO Summer Symposium
July 27, 2021
Celebrate and learn from prestigious awardees, lectureship recipients, and presenters at the ASPHO Summer Symposium! This special virtual event features research and presentations by individuals recognized for significant contributions to pediatric hematology/oncology.
Save the date to continue your learning and earn CME, applaud distinguished colleagues, and interact with participants on Tuesday, July 27, 9:30am – 3:00pm CT! The event is complimentary to 2021 ASPHO Conference registrants.
Welcome by ASPHO President Jorge Di Paola, MD
Recognizing Melissa Hudson, MD, and M. Monica Gramatges, MD
Northwestern Mutual Award for Excellence in Childhood Cancer Survivorship recipients
Throughout her career, Dr. Hudson has advocated for, initiated, and collaborated in the conduct of innovative intervention research among survivors of childhood cancer. Her leadership in promoting interventions of childhood cancer span a wide range of activities from design and testing of innovative intervention approaches to development and dissemination of clinical care guidelines. Dr. Hudson continues to lead the way in the conduct, promotion and facilitation of interventions designed to improve health and long-term outcomes through strategies designed to prevent or ameliorate adverse consequences of cancer and its treatment.
Dr. Gramatges has consistently demonstrated an extraordinary dedication to translational childhood cancer research, particularly in the area of survivorship. Dr. Gramatges is deserving of this award because of her research and publication track record, as well as for her ongoing advocacy for survivors of childhood cancer. She is equally dedicated to her patients as she is to her research, and clearly has a passion for improving the lives of survivors of childhood cancer through her clinical work, her research, and her work in the survivor community.
Professionals who focus on survivorship have chosen to devote considerable effort to helping pediatric cancer survivors live full and healthy lives. The Northwestern Mutual Award honors an emerging early or mid-career childhood cancer survivorship investigator who has demonstrated his or her commitment to this segment of the field through a growing portfolio of research and project funding, while accelerating in his or her output and gaining prominence.
Bone Marrow Failure and MDS: Lessons From Rare Diseases, Akiko Shimamura, MD PhD
Frank A. Oski Memorial Award and Lectureship recipient
The purpose of the annual Frank A. Oski Memorial Lectureship is to honor Dr. Oski's many contributions to the field of pediatric hematology/oncology and ensure a younger generation of pediatric hematology/oncology specialists remains aware of his legacy. The lectureship is awarded to an outstanding clinical or laboratory investigator in pediatric hematology/oncology whose cutting-edge research is of the caliber of the investigations made by Dr. Oski
- Summarize Precision Medicine approaches for pediatric bone marrow failure and MDS.
- Describe clinical implications of recent advances in the molecular pathogenesis of bone marrow failure and MDS.
Presentations by Alex Kentsis, MD PhD, and Kimberly Stegmaier, MD
St. Baldrick’s Foundation Robert J. Arceci Innovation Award Lectures
The St. Baldrick’s Foundation Robert J. Arceci Innovation Award reflects Dr. Arceci’s values, including thinking outside the box, international research, and development of the next generation of scientists.
The recipient of this award works in a research environment with mentoring and support conducive to continued academic success and innovation; has presented, published, or received funding for highly innovative research with the potential to lead to critical discoveries or major advancements that will accelerate important advances in our understanding of childhood cancer; and has demonstrated participation in team science, in addition to success in innovative discovery.
Recognizing Garrett Brodeur, MD
Distinguished Career Award recipient
Dr. Brodeur is a consummate physician scientist who has made major contributions to pediatric cancer in basic and translational research, mentorship, and leadership. He reported the first description of chromosomal aberrations in human neuroblastoma early in his career and has since made enormous contributions to our understanding of the molecular pathogenesis of human neuroblastomas. He has also been a leader in the development of international staging systems and treatment response criteria that are used throughout the world, among other significant contributions advancing the field. He has been, and remains, a giant in the field of pediatric oncology.
The Distinguished Career Award is presented annually by the American Society of Pediatric Hematology/Oncology to a senior physician who during his or her career has had a major impact on the subspecialty, through some combination of research, education, patient care and advocacy.
Artificial Intelligence Symposia with Patrick Leavey, MD, Ovidiu Daescu, PhD, and Anthony Chang, MD MBA MPH MS
Artificial Intelligence (AI) in Pediatric Hematology Oncology – Not Just a Neural Net!
Artificial intelligence (AI), within the discipline of which machine learning (ML) is an essential technique, delivers the potential to fundamentally affect healthcare. Digital image analysis using ML tools discerns malignant from benign lung nodules, adds to risk classification of glioma and accurately classifies clinical images of melanoma, while the field of natural language processing is beginning to analyze text-based data within the electronic medical record. Pediatric Hematologist/Oncologists who will with certainty experience the impact of AI in their patient care, will learn about this AI/Medicine intersection. The symposium addresses: AI 101 – What Is It?, Data Driven AI, and Case-based Study – AI at Work.
- Discuss the fundamental concepts of artificial intelligence and machine learning
- Identify the opportunities for application of artificial intelligence tools in the discipline of pediatric hematology/oncology
An Adventurer's Journey: Forty-Three Years as a Pediatric Hematologist Oncologist, Donald Mahoney, MD
George R. Buchanan Award and Lectureship
This presentation will provide reflections on a forty-three year adventure of discovery in pediatric hematology at Texas Children’s Cancer and Hematology Center. Clinical research endeavors in the fields of ALL, CNS tumors, bone marrow transplantation, and finally the transition to a broad array of challenging clinical problems within pediatric hematology will be briefly highlighted. These transitional stages were marked by challenges, uncertainties, some disappointments, as well as rewards and immense satisfaction. Career transitions within the institution were ultimately driven by real-time clinical needs assessment and by a drive to advocate for the best medical care for patients with hematological and/or oncological conditions, especially for patient groups that did not rise to a high interest level within our field of practice. This presentation will focus on the journey from protégé to mentor to the most satisfying role of co-mentor and will provide examples of how these mentorship experiences translated into major academic opportunities for fellows and junior faculty
- Recognize examples of clinical experiences and mentor interactions that can lead to academic opportunities for fellows and faculty
- Demonstrate the importance of interpersonal relationships in career development
- Recognize clinical opportunities for co-mentorship
Up to 4 AMA PRA Category 1 Credits™ available.
Mark your calendar for Tuesday, July 27, 9:30am – 3:00pm CT.